Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kensuke Takagi

Showing results (171-180 of 253) with videos related to

Pageof 26
Sort By:
Atherosclerosis|May 12, 2018
Association of skin autofluorescence with plaque vulnerability evaluated by optical coherence tomography in patients with cardiovascular diseaseYusuke Fujino, Guilherme F Attizzani, Satoko Tahara, et al.
The Canadian Journal of Cardiology|July 15, 2022
The Residual Lipid-Rich Coronary Atheroma Behind the Implanted Newer-Generation Drug-Eluting Stent and Future Stent-Related Event RisksKota Murai, Yu Kataoka, Stephen J Nicholls, et al.
European Heart Journal|May 24, 2026
Lipoprotein(a) and residual cardiovascular risks in Japanese patients with coronary artery disease who achieve guideline-recommended low-density lipoprotein cholesterol goalsYu Kataoka, Kausik K Ray, Stephen J Nicholls, et al.
The Canadian Journal of Cardiology|May 30, 2020
Clinical Impact of Preprocedural Moderate or Severe Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve ReplacementMizuki Miura, Kyohei Yamaji, Shinichi Shirai, et al.
The American Journal of Cardiology|August 4, 2018
Frequency and Consequences of Cognitive Impairmentin Patients Underwent Transcatheter Aortic Valve ImplantationRyo Yanagisawa, Makoto Tanaka, Fumiaki Yashima, et al.
JACC. Cardiovascular Interventions|November 1, 2020
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVRHideyuki Kawashima, Yusuke Watanabe, Hirofumi Hioki, et al.
BMJ Open|August 20, 2018
Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in JapanKazuki Mizutani, Masahiko Hara, Mana Nakao, et al.
Atherosclerosis|March 31, 2026
Achieving LDL-C <1.0 mmol/L and cardiovascular outcomes in patients with coronary artery disease who received percutaneous coronary interventionYu Kataoka, Stephen J Nicholls, Satoshi Kitahara, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 3, 2021
Impact of New York Heart Association Functional Class on Outcomes After Transcatheter Aortic Valve ImplantationTomohiko Taniguchi, Shinichi Shirai, Kenji Ando, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 28, 2021
Effect of Sex on Mortality and Left Ventricular Remodeling After Transcatheter Aortic Valve ImplantationKoki Shishido, Futoshi Yamanaka, Tomoki Ochiai, et al.
Pageof 26

Showing results (171-180 of 253) with videos related to

Sort By:
Pageof 26
Atherosclerosis|May 12, 2018
Association of skin autofluorescence with plaque vulnerability evaluated by optical coherence tomography in patients with cardiovascular diseaseYusuke Fujino, Guilherme F Attizzani, Satoko Tahara, et al.
The Canadian Journal of Cardiology|July 15, 2022
The Residual Lipid-Rich Coronary Atheroma Behind the Implanted Newer-Generation Drug-Eluting Stent and Future Stent-Related Event RisksKota Murai, Yu Kataoka, Stephen J Nicholls, et al.
European Heart Journal|May 24, 2026
Lipoprotein(a) and residual cardiovascular risks in Japanese patients with coronary artery disease who achieve guideline-recommended low-density lipoprotein cholesterol goalsYu Kataoka, Kausik K Ray, Stephen J Nicholls, et al.
The Canadian Journal of Cardiology|May 30, 2020
Clinical Impact of Preprocedural Moderate or Severe Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve ReplacementMizuki Miura, Kyohei Yamaji, Shinichi Shirai, et al.
The American Journal of Cardiology|August 4, 2018
Frequency and Consequences of Cognitive Impairmentin Patients Underwent Transcatheter Aortic Valve ImplantationRyo Yanagisawa, Makoto Tanaka, Fumiaki Yashima, et al.
JACC. Cardiovascular Interventions|November 1, 2020
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVRHideyuki Kawashima, Yusuke Watanabe, Hirofumi Hioki, et al.
BMJ Open|August 20, 2018
Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in JapanKazuki Mizutani, Masahiko Hara, Mana Nakao, et al.
Atherosclerosis|March 31, 2026
Achieving LDL-C <1.0 mmol/L and cardiovascular outcomes in patients with coronary artery disease who received percutaneous coronary interventionYu Kataoka, Stephen J Nicholls, Satoshi Kitahara, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 3, 2021
Impact of New York Heart Association Functional Class on Outcomes After Transcatheter Aortic Valve ImplantationTomohiko Taniguchi, Shinichi Shirai, Kenji Ando, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 28, 2021
Effect of Sex on Mortality and Left Ventricular Remodeling After Transcatheter Aortic Valve ImplantationKoki Shishido, Futoshi Yamanaka, Tomoki Ochiai, et al.
Pageof 26